{"entity":{"type":"insider","cik":"0001591256","url":"/insider/0001591256","json_url":"/insider/0001591256.json","name":"Hadjimichael Andreas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":98,"n_filings":47,"first":"2014-07-25","last":"2023-06-28","span_basis":"filed_date"},"name_variants":[{"name":"Hadjimichael Andreas","source":"filing","n_filings":47,"first_seen":"2014-07-25","last_seen":"2023-06-28"}],"transactions":[{"id":8079937,"accession":"0001213900-23-052442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-052442","line_url":"/filing/0001213900-23-052442#line-1","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Hadjimichael Andreas; Smolokowski Wiaczeslaw; Czernik Marcin; Nikolaou Anastasis","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16.0,"shares_display":"16","price_per_share":12.93,"price_display":"12.93","price_state":"stated","total_value":206.88,"total_display":"206.88","shares_owned_after":3848632.0,"shares_owned_after_display":"3,848,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-26","filed_date":"2023-06-28","scope":"insider"},{"id":8117836,"accession":"0001213900-23-050160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-050160","line_url":"/filing/0001213900-23-050160#line-1","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Hadjimichael Andreas; Czernik Marcin; Nikolaou Anastasis","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2056.0,"shares_display":"2,056","price_per_share":12.14,"price_display":"12.14","price_state":"stated","total_value":24959.84,"total_display":"24,959.84","shares_owned_after":3848648.0,"shares_owned_after_display":"3,848,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider"},{"id":8585857,"accession":"0001213900-23-049014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-23-049014","line_url":"/filing/0001213900-23-049014#line-3","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin; Nikolaou Anastasis; Hadjimichael Andreas","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":893.0,"shares_display":"893","price_per_share":12.13,"price_display":"12.13","price_state":"stated","total_value":10832.09,"total_display":"10,832.09","shares_owned_after":3850704.0,"shares_owned_after_display":"3,850,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-14","scope":"insider"},{"id":8585855,"accession":"0001213900-23-049014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-049014","line_url":"/filing/0001213900-23-049014#line-2","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin; Nikolaou Anastasis; Hadjimichael Andreas","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":12.3,"price_display":"12.30","price_state":"stated","total_value":36900.0,"total_display":"36,900.00","shares_owned_after":3851597.0,"shares_owned_after_display":"3,851,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":8585853,"accession":"0001213900-23-049014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-049014","line_url":"/filing/0001213900-23-049014#line-1","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin; Nikolaou Anastasis; Hadjimichael Andreas","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.34,"price_display":"12.34","price_state":"stated","total_value":24680.0,"total_display":"24,680.00","shares_owned_after":3854597.0,"shares_owned_after_display":"3,854,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-14","scope":"insider"},{"id":6736181,"accession":"0001213900-22-074313","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-22-074313","line_url":"/filing/0001213900-22-074313#line-3","is_derivative":false,"issuer_cik":"0001590232","issuer_name":"Acrivon Therapeutics, Inc.","issuer_ticker":"ACRV","issuer_name_source":null,"issuer_url":"/issuer/0001590232","owner_cik":null,"owner_name":"Chione Ltd; Czernik Marcin; Nikolaou Anastasis; Hadjimichael Andreas; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","shares_owned_after":3856597.0,"shares_owned_after_display":"3,856,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider"},{"id":8704295,"accession":"0001213900-19-003551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-003551","line_url":"/filing/0001213900-19-003551#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Hadjimichael George; Chione Ltd; Smolokowski Wiaczeslaw; Hadjimichael Andreas","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149624.0,"shares_display":"149,624","price_per_share":4.1378,"price_display":"4.14","price_state":"stated","total_value":619114.1872,"total_display":"619,114.19","shares_owned_after":6000000.0,"shares_owned_after_display":"6,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-28","filed_date":"2019-03-04","scope":"insider"},{"id":8729615,"accession":"0001213900-19-003242","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-19-003242","line_url":"/filing/0001213900-19-003242#line-3","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Czernik Marcin; Hadjimichael Andreas; Hadjimichael George; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":558243.0,"shares_display":"558,243","price_per_share":4.5067,"price_display":"4.51","price_state":"stated","total_value":2515833.7281,"total_display":"2,515,833.73","shares_owned_after":6149624.0,"shares_owned_after_display":"6,149,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-27","filed_date":"2019-02-27","scope":"insider"},{"id":8729612,"accession":"0001213900-19-003242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-19-003242","line_url":"/filing/0001213900-19-003242#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Czernik Marcin; Hadjimichael Andreas; Hadjimichael George; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":123400.0,"shares_display":"123,400","price_per_share":5.0017,"price_display":"5.00","price_state":"stated","total_value":617209.78,"total_display":"617,209.78","shares_owned_after":6707867.0,"shares_owned_after_display":"6,707,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-27","scope":"insider"},{"id":8729608,"accession":"0001213900-19-003242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-003242","line_url":"/filing/0001213900-19-003242#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Czernik Marcin; Hadjimichael Andreas; Hadjimichael George; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800000.0,"shares_display":"800,000","price_per_share":4.9936,"price_display":"4.99","price_state":"stated","total_value":3994880.0,"total_display":"3,994,880.00","shares_owned_after":6831267.0,"shares_owned_after_display":"6,831,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider"},{"id":6480209,"accession":"0001213900-18-012296","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-012296","line_url":"/filing/0001213900-18-012296#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Czernik Marcin; Chione Ltd; Hadjimichael Andreas; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":20.5154,"price_display":"20.52","price_state":"stated","total_value":98473.92,"total_display":"98,473.92","shares_owned_after":7631267.0,"shares_owned_after_display":"7,631,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-06","filed_date":"2018-09-07","scope":"insider"},{"id":6480206,"accession":"0001213900-18-012296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-012296","line_url":"/filing/0001213900-18-012296#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Czernik Marcin; Chione Ltd; Hadjimichael Andreas; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160000.0,"shares_display":"160,000","price_per_share":21.0641,"price_display":"21.06","price_state":"stated","total_value":3370256.0,"total_display":"3,370,256.00","shares_owned_after":7636067.0,"shares_owned_after_display":"7,636,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-07","scope":"insider"},{"id":6080736,"accession":"0001213900-18-012091","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-18-012091","line_url":"/filing/0001213900-18-012091#line-3","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Chione Ltd; Czernik Marcin; Hadjimichael Andreas; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":20.6018,"price_display":"20.60","price_state":"stated","total_value":824072.0,"total_display":"824,072.00","shares_owned_after":7796067.0,"shares_owned_after_display":"7,796,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-04","scope":"insider"},{"id":6080733,"accession":"0001213900-18-012091","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-012091","line_url":"/filing/0001213900-18-012091#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Chione Ltd; Czernik Marcin; Hadjimichael Andreas; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11468.0,"shares_display":"11,468","price_per_share":21.0495,"price_display":"21.05","price_state":"stated","total_value":241395.666,"total_display":"241,395.67","shares_owned_after":7836067.0,"shares_owned_after_display":"7,836,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-31","filed_date":"2018-09-04","scope":"insider"},{"id":6080730,"accession":"0001213900-18-012091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-012091","line_url":"/filing/0001213900-18-012091#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Chione Ltd; Czernik Marcin; Hadjimichael Andreas; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":20.9995,"price_display":"21.00","price_state":"stated","total_value":4199900.0,"total_display":"4,199,900.00","shares_owned_after":7847535.0,"shares_owned_after_display":"7,847,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-30","filed_date":"2018-09-04","scope":"insider"},{"id":6663549,"accession":"0001213900-18-011892","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-011892","line_url":"/filing/0001213900-18-011892#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Hadjimichael Andreas; Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":19.5914,"price_display":"19.59","price_state":"stated","total_value":3918280.0,"total_display":"3,918,280.00","shares_owned_after":8047535.0,"shares_owned_after_display":"8,047,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-29","filed_date":"2018-08-29","scope":"insider"},{"id":6663547,"accession":"0001213900-18-011892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-011892","line_url":"/filing/0001213900-18-011892#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Hadjimichael Andreas; Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14026.0,"shares_display":"14,026","price_per_share":18.521,"price_display":"18.52","price_state":"stated","total_value":259775.546,"total_display":"259,775.55","shares_owned_after":8247535.0,"shares_owned_after_display":"8,247,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-27","filed_date":"2018-08-29","scope":"insider"},{"id":6561083,"accession":"0001213900-18-011094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-011094","line_url":"/filing/0001213900-18-011094#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Hadjimichael George; Smolokowski Wiaczeslaw; Hadjimichael Andreas; Chione Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":702.0,"shares_display":"702","price_per_share":18.5,"price_display":"18.50","price_state":"stated","total_value":12987.0,"total_display":"12,987.00","shares_owned_after":8261561.0,"shares_owned_after_display":"8,261,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-10","filed_date":"2018-08-14","scope":"insider"},{"id":5967174,"accession":"0001213900-18-010635","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-18-010635","line_url":"/filing/0001213900-18-010635#line-3","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Smolokowski Wiaczeslaw; Chione Ltd; Czernik Marcin; Hadjimichael Andreas; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67474.0,"shares_display":"67,474","price_per_share":18.5076,"price_display":"18.51","price_state":"stated","total_value":1248781.8024,"total_display":"1,248,781.80","shares_owned_after":8262263.0,"shares_owned_after_display":"8,262,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-09","filed_date":"2018-08-09","scope":"insider"},{"id":5967171,"accession":"0001213900-18-010635","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-010635","line_url":"/filing/0001213900-18-010635#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Smolokowski Wiaczeslaw; Chione Ltd; Czernik Marcin; Hadjimichael Andreas; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":18.6066,"price_display":"18.61","price_state":"stated","total_value":52098.48,"total_display":"52,098.48","shares_owned_after":8329737.0,"shares_owned_after_display":"8,329,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-08","filed_date":"2018-08-09","scope":"insider"},{"id":5967170,"accession":"0001213900-18-010635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-010635","line_url":"/filing/0001213900-18-010635#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Smolokowski Wiaczeslaw; Chione Ltd; Czernik Marcin; Hadjimichael Andreas; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10602.0,"shares_display":"10,602","price_per_share":18.6,"price_display":"18.60","price_state":"stated","total_value":197197.2,"total_display":"197,197.20","shares_owned_after":8332537.0,"shares_owned_after_display":"8,332,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-07","filed_date":"2018-08-09","scope":"insider"},{"id":6914578,"accession":"0001213900-18-009659","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-18-009659","line_url":"/filing/0001213900-18-009659#line-3","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Hadjimichael Andreas; Smolokowski Wiaczeslaw; Hadjimichael George; Chione Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":895.0,"shares_display":"895","price_per_share":18.5151,"price_display":"18.52","price_state":"stated","total_value":16571.0145,"total_display":"16,571.01","shares_owned_after":8343139.0,"shares_owned_after_display":"8,343,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-25","filed_date":"2018-07-25","scope":"insider"},{"id":6914574,"accession":"0001213900-18-009659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-009659","line_url":"/filing/0001213900-18-009659#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Hadjimichael Andreas; Smolokowski Wiaczeslaw; Hadjimichael George; Chione Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9144.0,"shares_display":"9,144","price_per_share":18.6288,"price_display":"18.63","price_state":"stated","total_value":170341.7472,"total_display":"170,341.75","shares_owned_after":8344034.0,"shares_owned_after_display":"8,344,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-24","filed_date":"2018-07-25","scope":"insider"},{"id":6914565,"accession":"0001213900-18-009659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-009659","line_url":"/filing/0001213900-18-009659#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Hadjimichael Andreas; Smolokowski Wiaczeslaw; Hadjimichael George; Chione Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":18.6611,"price_display":"18.66","price_state":"stated","total_value":373222.0,"total_display":"373,222.00","shares_owned_after":8353178.0,"shares_owned_after_display":"8,353,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-25","scope":"insider"},{"id":6730977,"accession":"0001213900-18-009536","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-009536","line_url":"/filing/0001213900-18-009536#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Hadjimichael Andreas; Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26742.0,"shares_display":"26,742","price_per_share":19.2134,"price_display":"19.21","price_state":"stated","total_value":513804.7428,"total_display":"513,804.74","shares_owned_after":8373178.0,"shares_owned_after_display":"8,373,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-20","filed_date":"2018-07-23","scope":"insider"},{"id":6730973,"accession":"0001213900-18-009536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-009536","line_url":"/filing/0001213900-18-009536#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Hadjimichael Andreas; Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":18.8994,"price_display":"18.90","price_state":"stated","total_value":1889940.0,"total_display":"1,889,940.00","shares_owned_after":8399920.0,"shares_owned_after_display":"8,399,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-19","filed_date":"2018-07-23","scope":"insider"},{"id":6610045,"accession":"0001213900-18-009395","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-18-009395","line_url":"/filing/0001213900-18-009395#line-3","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Smolokowski Wiaczeslaw; Chione Ltd; Hadjimichael Andreas; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":18.5335,"price_display":"18.53","price_state":"stated","total_value":556005.0,"total_display":"556,005.00","shares_owned_after":8499920.0,"shares_owned_after_display":"8,499,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-18","filed_date":"2018-07-18","scope":"insider"},{"id":6610041,"accession":"0001213900-18-009395","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-18-009395","line_url":"/filing/0001213900-18-009395#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Smolokowski Wiaczeslaw; Chione Ltd; Hadjimichael Andreas; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17346.0,"shares_display":"17,346","price_per_share":18.5,"price_display":"18.50","price_state":"stated","total_value":320901.0,"total_display":"320,901.00","shares_owned_after":8529920.0,"shares_owned_after_display":"8,529,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-17","filed_date":"2018-07-18","scope":"insider"},{"id":6610038,"accession":"0001213900-18-009395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-18-009395","line_url":"/filing/0001213900-18-009395#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Smolokowski Wiaczeslaw; Chione Ltd; Hadjimichael Andreas; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2654.0,"shares_display":"2,654","price_per_share":18.5233,"price_display":"18.52","price_state":"stated","total_value":49160.8382,"total_display":"49,160.84","shares_owned_after":8547266.0,"shares_owned_after_display":"8,547,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-16","filed_date":"2018-07-18","scope":"insider"},{"id":2142748,"accession":"0001213900-16-014500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-014500","line_url":"/filing/0001213900-16-014500#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Hadjimichael Andreas; Chione Ltd; Czernik Marcin; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18824.0,"shares_display":"18,824","price_per_share":8.0261,"price_display":"8.03","price_state":"stated","total_value":151083.3064,"total_display":"151,083.31","shares_owned_after":8549920.0,"shares_owned_after_display":"8,549,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-23","filed_date":"2016-06-27","scope":"insider"},{"id":2891231,"accession":"0001213900-16-014246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-014246","line_url":"/filing/0001213900-16-014246#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael Andreas; Hadjimichael George; Czernik Marcin; Smolokowski Wiaczeslaw; Chione Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7074.0,"shares_display":"7,074","price_per_share":8.512,"price_display":"8.51","price_state":"stated","total_value":60213.888,"total_display":"60,213.89","shares_owned_after":8568744.0,"shares_owned_after_display":"8,568,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-13","filed_date":"2016-06-15","scope":"insider"},{"id":2559403,"accession":"0001213900-16-014152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-16-014152","line_url":"/filing/0001213900-16-014152#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Hadjimichael Andreas; Czernik Marcin; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":9.1366,"price_display":"9.14","price_state":"stated","total_value":274098.0,"total_display":"274,098.00","shares_owned_after":8575818.0,"shares_owned_after_display":"8,575,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-09","filed_date":"2016-06-10","scope":"insider"},{"id":2559398,"accession":"0001213900-16-014152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-014152","line_url":"/filing/0001213900-16-014152#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Smolokowski Wiaczeslaw; Hadjimichael Andreas; Czernik Marcin; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15541.0,"shares_display":"15,541","price_per_share":9.3421,"price_display":"9.34","price_state":"stated","total_value":145185.5761,"total_display":"145,185.58","shares_owned_after":8605818.0,"shares_owned_after_display":"8,605,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-08","filed_date":"2016-06-10","scope":"insider"},{"id":2929599,"accession":"0001213900-16-014107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-16-014107","line_url":"/filing/0001213900-16-014107#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Hadjimichael Andreas; Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":9.2543,"price_display":"9.25","price_state":"stated","total_value":185086.0,"total_display":"185,086.00","shares_owned_after":8621359.0,"shares_owned_after_display":"8,621,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-08","scope":"insider"},{"id":2929595,"accession":"0001213900-16-014107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-014107","line_url":"/filing/0001213900-16-014107#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Hadjimichael Andreas; Chione Ltd; Smolokowski Wiaczeslaw; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":9.2232,"price_display":"9.22","price_state":"stated","total_value":184464.0,"total_display":"184,464.00","shares_owned_after":8641359.0,"shares_owned_after_display":"8,641,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-08","scope":"insider"},{"id":2836625,"accession":"0001213900-16-014045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-014045","line_url":"/filing/0001213900-16-014045#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Smolokowski Wiaczeslaw; Chione Ltd; Hadjimichael Andreas; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17855.0,"shares_display":"17,855","price_per_share":9.6468,"price_display":"9.65","price_state":"stated","total_value":172243.614,"total_display":"172,243.61","shares_owned_after":8661359.0,"shares_owned_after_display":"8,661,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-02","filed_date":"2016-06-06","scope":"insider"},{"id":2480457,"accession":"0001213900-16-013967","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-16-013967","line_url":"/filing/0001213900-16-013967#line-3","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Smolokowski Wiaczeslaw; Hadjimichael Andreas; Chione Ltd; Hadjimichael George; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17568.0,"shares_display":"17,568","price_per_share":9.6384,"price_display":"9.64","price_state":"stated","total_value":169327.4112,"total_display":"169,327.41","shares_owned_after":8679214.0,"shares_owned_after_display":"8,679,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-01","scope":"insider"},{"id":2480448,"accession":"0001213900-16-013967","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-16-013967","line_url":"/filing/0001213900-16-013967#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Smolokowski Wiaczeslaw; Hadjimichael Andreas; Chione Ltd; Hadjimichael George; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17096.0,"shares_display":"17,096","price_per_share":9.6556,"price_display":"9.66","price_state":"stated","total_value":165072.1376,"total_display":"165,072.14","shares_owned_after":8696782.0,"shares_owned_after_display":"8,696,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-01","scope":"insider"},{"id":2480436,"accession":"0001213900-16-013967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-013967","line_url":"/filing/0001213900-16-013967#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Smolokowski Wiaczeslaw; Hadjimichael Andreas; Chione Ltd; Hadjimichael George; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":9.58,"price_display":"9.58","price_state":"stated","total_value":383200.0,"total_display":"383,200.00","shares_owned_after":8713878.0,"shares_owned_after_display":"8,713,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-27","filed_date":"2016-06-01","scope":"insider"},{"id":2062604,"accession":"0001213900-16-013868","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-16-013868","line_url":"/filing/0001213900-16-013868#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Czernik Marcin; Chione Ltd; Hadjimichael Andreas; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18182.0,"shares_display":"18,182","price_per_share":9.5857,"price_display":"9.59","price_state":"stated","total_value":174287.1974,"total_display":"174,287.20","shares_owned_after":8753878.0,"shares_owned_after_display":"8,753,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-26","filed_date":"2016-05-27","scope":"insider"},{"id":2062599,"accession":"0001213900-16-013868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-013868","line_url":"/filing/0001213900-16-013868#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Czernik Marcin; Chione Ltd; Hadjimichael Andreas; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27940.0,"shares_display":"27,940","price_per_share":9.8261,"price_display":"9.83","price_state":"stated","total_value":274541.234,"total_display":"274,541.23","shares_owned_after":8772060.0,"shares_owned_after_display":"8,772,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-27","scope":"insider"},{"id":2380219,"accession":"0001213900-16-013765","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-16-013765","line_url":"/filing/0001213900-16-013765#line-3","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Hadjimichael Andreas; Czernik Marcin; Hadjimichael George; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33932.0,"shares_display":"33,932","price_per_share":8.765,"price_display":"8.76","price_state":"stated","total_value":297413.98,"total_display":"297,413.98","shares_owned_after":8800000.0,"shares_owned_after_display":"8,800,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-23","scope":"insider"},{"id":2380210,"accession":"0001213900-16-013765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-16-013765","line_url":"/filing/0001213900-16-013765#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Hadjimichael Andreas; Czernik Marcin; Hadjimichael George; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":8.5187,"price_display":"8.52","price_state":"stated","total_value":340748.0,"total_display":"340,748.00","shares_owned_after":8833932.0,"shares_owned_after_display":"8,833,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-23","scope":"insider"},{"id":2380203,"accession":"0001213900-16-013765","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-013765","line_url":"/filing/0001213900-16-013765#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Hadjimichael Andreas; Czernik Marcin; Hadjimichael George; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":8.1822,"price_display":"8.18","price_state":"stated","total_value":163644.0,"total_display":"163,644.00","shares_owned_after":8873932.0,"shares_owned_after_display":"8,873,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-19","filed_date":"2016-05-23","scope":"insider"},{"id":2290199,"accession":"0001213900-16-013630","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-16-013630","line_url":"/filing/0001213900-16-013630#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Hadjimichael Andreas; Hadjimichael George; Smolokowski Wiaczeslaw; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":8.1496,"price_display":"8.15","price_state":"stated","total_value":244488.0,"total_display":"244,488.00","shares_owned_after":8893932.0,"shares_owned_after_display":"8,893,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":2290185,"accession":"0001213900-16-013630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-013630","line_url":"/filing/0001213900-16-013630#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Chione Ltd; Hadjimichael Andreas; Hadjimichael George; Smolokowski Wiaczeslaw; Czernik Marcin","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33800.0,"shares_display":"33,800","price_per_share":8.1503,"price_display":"8.15","price_state":"stated","total_value":275480.14,"total_display":"275,480.14","shares_owned_after":8923932.0,"shares_owned_after_display":"8,923,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-17","filed_date":"2016-05-19","scope":"insider"},{"id":2891228,"accession":"0001213900-16-013570","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-16-013570","line_url":"/filing/0001213900-16-013570#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Czernik Marcin; Hadjimichael Andreas; Chione Ltd; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.0065,"price_display":"8.01","price_state":"stated","total_value":80065.0,"total_display":"80,065.00","shares_owned_after":8957732.0,"shares_owned_after_display":"8,957,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-17","scope":"insider"},{"id":2891224,"accession":"0001213900-16-013570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-013570","line_url":"/filing/0001213900-16-013570#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Hadjimichael George; Czernik Marcin; Hadjimichael Andreas; Chione Ltd; Smolokowski Wiaczeslaw","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":8.0087,"price_display":"8.01","price_state":"stated","total_value":3203.48,"total_display":"3,203.48","shares_owned_after":8967732.0,"shares_owned_after_display":"8,967,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-13","filed_date":"2016-05-17","scope":"insider"},{"id":2793795,"accession":"0001213900-16-013228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-16-013228","line_url":"/filing/0001213900-16-013228#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Chione Ltd; Smolokowski Wiaczeslaw; Hadjimichael Andreas; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11868.0,"shares_display":"11,868","price_per_share":8.4142,"price_display":"8.41","price_state":"stated","total_value":99859.7256,"total_display":"99,859.73","shares_owned_after":8968132.0,"shares_owned_after_display":"8,968,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-11","filed_date":"2016-05-12","scope":"insider"},{"id":2793788,"accession":"0001213900-16-013228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-16-013228","line_url":"/filing/0001213900-16-013228#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":null,"owner_name":"Czernik Marcin; Chione Ltd; Smolokowski Wiaczeslaw; Hadjimichael Andreas; Hadjimichael George","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":8.1394,"price_display":"8.14","price_state":"stated","total_value":162788.0,"total_display":"162,788.00","shares_owned_after":8980000.0,"shares_owned_after_display":"8,980,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-10","filed_date":"2016-05-12","scope":"insider"}],"next_cursor":"2016-05-10|2793788","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001781174","name":"Acrivon Therapeutics, Inc.","url":"/issuer/0001781174","role":"Ten percent owner","n_filings":4,"first_seen":"2022-11-21","last_seen":"2023-06-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Ten percent owner","n_filings":43,"first_seen":"2014-07-25","last_seen":"2019-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001591256","retrieved_at":"2026-08-21T01:56:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}